Filing Details

Accession Number:
0001062993-24-011338
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-28 16:22:47
Reporting Period:
2024-05-23
Accepted Time:
2024-05-28 16:22:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267565 Collegium Pharmaceutical Inc COLL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746251 Scott Dreyer C/O Collegium Pharmaceutical, Inc.
100 Technology Center Drive
Stoughton MA 02072
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-23 51,209 $24.03 190,127 No 4 M Direct
Common Stock Disposition 2024-05-23 51,209 $33.82 138,918 No 4 S Direct
Common Stock Acquisiton 2024-05-24 23,791 $24.03 162,709 No 4 M Direct
Common Stock Disposition 2024-05-24 56,807 $33.98 105,902 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Purchase) Disposition 2024-05-23 51,209 $0.00 51,209 $24.03
Common Stock Stock Option (Right to Purchase) Disposition 2024-05-24 23,791 $0.00 23,791 $24.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,791 2028-04-04 No 4 M Direct
0 2028-04-04 No 4 M Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.36 to $34.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.68 to $34.25, inclusive.
  3. The option is fully vested and exercisable.